Epidemiologic aspects of hypertension in old age;Aspetti epidemiologici dell'ipertensione arteriosa nell'anziano

Giornale di Gerontologia

Volumn 52, Issue 5, 2004, Pages 331-337

  Di Bari, Mauro ^a   Lambertucci, L ^a   Pozzi, C ^a   Virgillio, A ^a   Ungar, A ^a   Masotti, G ^a   Marchionni, N ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiovascular risk; Elderly; Epidemiology; Hypertension

Indexed keywords

AGING; AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; HYPERTENSION; INCIDENCE; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 25444519257     PISSN: 00170305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. 3 European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
3. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J 1985;291:97-104.
4. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
5. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45.
6. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
7. Ferrucci L, Furberg CD, Penninx BW, Di Bari M, Williamson JD, Guralnik JM, et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001;104:1923-6.
8. American Heart Association. High blood pressure. Heart disease and stroke statistics - 2004 update. 2003, pp. 17-19.
9. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72.
10. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920-7.
11. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. The Italian Longitudinal Study on Aging Working Group. Int J Epidemiol 1997;26:995-1002.
12. Di Bari M, Salti F, Nardi M, Pahor M, De Fusco C, Tonon E, et al. Undertreatment of hypertension in community dwelling older adults: a drug-utilization study in Dicomano, Italy. J Hypert 1999; 17:1633-40.
13. Casiglia E, Mazza A, Tikhonoff V, Pavei A, Privato G, Schenal N, et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J Hum Hypertens 2002;16:21-31.
14. Di Bari M, Marchionni N, Matteuzzi D, Ungar A, Ferrucci L, Masotti G. Epidemiologia dell'ipertensione arteriosa nell'anziano a rischio. G Gerontol 2002;50:237-47.
15. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
16. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US bypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-74.
17. Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 2002;162:2325-32.
18. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6.
19. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
20. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995;345:825-9.
21. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 1970;214:301-10.
22. Kannel WB. Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging 2003;20:277-86.
23. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
24. Pini R, Cavallini MC, Bencini F, Staglianò L, Tonon E, Innocenti F, et al. Cardiac and Vascular Remodeling in Older Adults With Borderline Isolated Systolic Hypertension: The ICARe Dicomano Study. Hypertension 2001;38:1372-6.
25. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989;13:392-400.
26. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998;16:747-52.
27. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
28. Mattace-Raso FU, van der Cammen TJ, van Popele NM, van der Kuip DA, Schalekamp MA, Hofman A, et al. Blood pressure components and cardiovascular events in older adults: the Rotterdam study. J Am Geriatr Soc 2004;52:1538-42.
29. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K, et al. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension 2001;38:232-7.
30. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000;102:1139-44.
31. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000;320:1128-34.
32. Staessen JA, Thijs L, O'Brien ET, Bulpitt CJ, de Leeuw PW, Fagard RH, et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002;15:835-43.
33. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995;13:1377-90.
34. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998;32:255-9.
35. Verdecchia P, Reboldi G, Porcellati C, Schillaci G, Pede S, Bentivoglio M, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol 2002;39:878-85.
36. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings inpatients with treated hypertension. N Engl J Med 2003;348:2407-15.
37. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004;22:1691-7.
38. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001;104:1385-92.
39. Imai Y, Tsuji I, Nagai K, Sakuma M, Ohkubo T, Watanabe N, et al. Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese community. Hypertens Res 1996;19:207-12.
40. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002;40:795-6.
41. Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H. Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens 1998;16:1415-24.
42. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988;259:225-8.
43. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999;34:267-72.
44. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999;4:303-17.
45. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.